Pharma Journalist -

SMi Group reports: Explore design strategies for connectivity and digital health at Wearable Injectors and Connected Devices conference 2021 The 2nd annual Wearable Injectors and…
Read More...

Celltrion Healthcare Canada Limited announced today that the New Drug Submission (NDS) file for regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19, submitted to Health…
Read More...

GC Pharma and Tottori University announced a worldwide licensing and collaboration agreement for the orally administrable chaperone drug of GM1 gangliosidosis (GM1). GM1 is one of the…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization (EUA) for the investigational COVID-19 antibody…
Read More...

Minovia Therapeutics, Ltd. and Astellas Pharma Inc. announced a worldwide strategic collaboration and license agreement for the research, development, and commercialization of novel…
Read More...

SMi Reports: A free webinar led by Zeiss will take place on 7th September2021 to explore  new approaches using X ray Microscopy (XRM) from nano- to micro-scale  SMi Group is…
Read More...

Entering the fourth wave of protein engineering, increasingly more companies are engaging with ML and AI to progress R&D projects and entrants are shifting their focus to cover in…
Read More...

Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners (Frazier) announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and…
Read More...

Shuttle Pharmaceuticals Holdings, Inc (Shuttle Pharma), a Maryland-based developer of new drugs for cancer treatment, was awarded US Patent No.: 11,034,667 B2 for "Selective Histone…
Read More...

Allergan, an AbbVie company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of BOTOX to include eight new muscles for the treatment of…
Read More...